Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2020 Results Conference Call October 29, 2020 4:00 PM ET Company Participants Marek Ciszewski - Director, IR Panna Sharma - President and CEO David Margrave - CFO Conference Call Participants Kyle Bauser - Colliers John Vandermosten - Zacks Small Cap Operator Good afternoon and welcome to Lantern Pharma’s Third Quarter 2020 Conference Call. As a reminder, this call is being recorded and all participants are in listen-only mode. We will open the call for questions-and-ans ...

| --- | --- | --- | |------------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | | Leveraging A.I., Machine Learning & Genomics to Rescue, Repurpose and | | | | Develop Targeted Cancer Therapies | | | SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS • This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These ...